256 results on '"Fradelizi D"'
Search Results
2. Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ
Catalog
Books, media, physical & digital resources
3. L’échographie haute résolution de la souris
4. Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice
5. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA)
6. In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA)
7. Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-α)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13
8. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes
9. Modification of the Regulation of Interleukin 2 (IL2) in Human Breast Cancer
10. INTERLEUKIN 2 (IL2) PRODUCTION BY LYMPHOCYTES OF HUMAN BREAST CANCER PATIENTS
11. PRODUCTION, PURIFICATION AND BIOLOGICAL ACTIVITIES OF NATURAL HUMAN INTERLEUKIN 2
12. Évaluation des arthrites expérimentales par échographie haute résolution et Doppler chez la souris
13. G.P.6.14 Cardiac characterization of mdx mice using high-resolution echocardiography
14. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human V gamma/V delta 2 T cells in tumor immunity
15. Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells
16. In vitrodifferentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA)
17. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy
18. Encapsulation in hollow fibers of cells engineered to secrete IL-4 or IL-13 in the treatment of experimental arthritis
19. Signaling through CD82 and other tetraspanins induces sustained morphological changes involved in T cell activation
20. The engagement of CD82 is a costimulatory signal inducing cytokines production by normal resting or in vitro differentiated T lymphocytes
21. Modulation of pro-inflammatory cytokine production with IL-4, IL-10 or IL-13 in TNF-α transgenic mice
22. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.
23. Les cytokines ont 20 ans: de la culture cellulaire aux applications thérapeutiques
24. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation.
25. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats.
26. Evidence for a Hyperexcitability State of Staggerer Mutant Mice Macrophages
27. Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration
28. Cytokines and neuronal degeneration in cerebellar mutant mice
29. Interleukin-1 Hyperproduction by In Vitro Activated Peripheral Macrophages from Cerebellar Mutant Mice
30. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity
31. Human Ia-like DRw lymphocyte antigens stimulating activity in primary mixed lymphocyte reaction.
32. The role of the Fc receptor (FcR) of thymus-derived lymphocytes II. Presence of FcR on suppressor cells and direct involvement in suppression.
33. Functional Study and Detection of HLA- D Products on Fractionated Human Bone Marrow Cells.
34. Third HL-A Segregant Series: Genetic Analysis and Molecular Independence on Lymphocyte Surface.
35. ALLOGRAFT TOLERANCE IN PIGS AFTER FRACTIONATED LYMPHOID IRRADIATION.
36. ALLOGRAFT TOLERANCE IN PIGS AFTER FRACTIONATED LYMPHOID IRRADIATION.
37. Mixed lymphocyte reactivity of human lymphocytes primed in vitro. I. Secondary response to allogenic lymphocytes.
38. Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.
39. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.
40. Leukemia cell lines can replace monocytes for mitogen-induced T-lymphocyte responses: this accessory function is dependent upon their differentiation stage.
41. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
42. Interferon inhibits the generation of allospecific suppressor T lymphocytes.
43. CRITICAL EVALUATION OF HISTOCOMPATIBILITY IN 179 RENAL TRANSPLANTS
44. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes
45. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation
46. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells
47. HLA-DR specific human suppressor lymphocytes generated by repeated in vitro sensitisation against allogeneic cells.
48. [Treatment of inflammation with anti-inflammatory cytokines: example in models of auto-immune diseases]
49. Inhibition of tumor growth induced by the injection of histo-incompatible cells expressing interleukin-2,INHIBITION DE LA CROISSANCE TUMORALE INDUITE PAR L'INJECTION DE CELLULES HISTO-INCOMPATIBLES PRODUISANT DE L'INTERLEUKINE-2
50. [Experimental gene therapy in models of inflammatory arthritis]
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.